Your institution may have access to this item. Find your institution then sign in to continue.
Title
Under the skin.
Abstract
The article looks at the importance of using Enhanze technology from Halozyme Therapeutics Inc. to deliver the biologic herceptin subcutaneously for breast caner patients. It notes that the device increases the absorption and dispersion of biologics under the skin as well as allow patients to either self-administer subcutaneous herceptin at home. It further states that the technology allows administration of up to five times more volume than normally viable via subcutaneously injected medicines.